TGFB1 Antikörper (AA 22-50)
Kurzübersicht für TGFB1 Antikörper (AA 22-50) (ABIN1809827)
Target
Alle TGFB1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 22-50
-
Spezifität
- This TGFB1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 22-50 amino acids from the N-terminal region of human TGFB1.
-
Aufreinigung
- Protein A purified
-
-
-
-
Applikationshinweise
- Approved: IF (1:10 - 1:50), IHC, IHC-P (1:10 - 1:50), WB (1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Haltbarkeit
- 6 months
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Andere Bezeichnung
- TGFB1 / TGF Beta 1
-
Hintergrund
-
Name/Gene ID: TGFB1
Family: TGF beta
Synonyms: TGFB1, CED, DPD1, Diaphyseal dysplasia 1, LAP, Latency-associated peptide, TGF Beta, TGFbeta, TGF-beta 1 protein, TGF-beta-1, TGFB -
Gen-ID
- 7040
-
UniProt
- P01137
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints
Target
-